2022 Diversity In Cancer Care Webinars | Clinical Trials

2022 Diversity in Cancer Care Webinars | Clinical Trials

Total Health | Oncology

2022 Diversity in Cancer Care Webinars | Clinical Practice

Total Health | Oncology

2022 Diversity in Cancer Care Webinars | Fireside Chat

Total Health | Oncology

Diversity and Inclusion in Clinical Trials | Stanford Cancer Institute

Stanford Cancer Institute

Diversity in Cancer Care | Genitourinary Cancers | Equity in Access to Clinical Trials

Total Health | Oncology

Diversity in Breast Cancer Clinical Trials

LurieCancerCenter

Understanding Clinical Trials in Cancer Care

UT Southwestern Medical Center

Diversity in Cancer Care | Breast Cancer | Access to Clinical Trials

Total Health | Oncology

10th Anniversary and 8th Research Conference 2024 - Day 3

Enhancing Diversity in Cancer Clinical Trials

Why is it important to have diversity in lung cancer clinical trials?

You and Lung Cancer

Clinical Trials and Cancer Immunotherapy: Accessing Promising Treatments

Cancer Research Institute

Clinical Trials 101 | 2022-2023 EMBRACE MBC Virtual Forum Series

Dana-Farber Cancer Institute

Innovations in Cancer Clinical Trials 2022

OCRA

Phases of Cancer Clinical Trials – An Introduction, with Neal Meropol, MD

Clinical Trials: Why Diversity Matters

The University of Kansas Cancer Center

The Impact of Clinical Trials in Cancer Care

Rutgers Cancer Institute

Seminar Clips: Diversity in Clinical Trials- Robert A. Winn, MD | Stanford Cancer Institute

Stanford Cancer Institute

Clinical Trials: Why Diversity Matters (30 Seconds)

The University of Kansas Cancer Center

Dr. Howard Hochster Discusses the Importance of Clinical Trials in Oncology

Rutgers Cancer Institute